Article

Scotia Vision, i2eye Consulting merge

Scotia Vision LLC and i2eye Consulting LLC are merging in a move designed to strengthen the former company?s business model. The combined entity will be known as Scotia Vision.

Tampa, FL-Scotia Vision LLC and i2eye Consulting LLC are merging in a move designed to strengthen the former company’s business model. The combined entity will be known as Scotia Vision.

Michael O’Rourke and Susan Benton, founders and managing partners of Scotia Vision and i2eye, respectively, will be equal partners in the new entity. They have a combined experience of 30 years in the ophthalmic industry.

Before establishing Scotia Vision, a consultant to pharmaceutical, drug delivery, and device companies, O’Rourke was general manager of the Bausch + Lomb (B+L) U.S. pharmaceutical division. Before i2eye Consulting, which advises ophthalmic companies on commercialization matters, Benton was co-founder and senior vice president of commercial operations for Sirion Therapeutics. She also worked for B+L as the head of pharmaceutical sales and commercial operations, where she launched the company’s first branded pharmaceutical products.

“This transaction reinforces current strengths of Scotia Vision and the strategy to create a world-class ophthalmic practice,” said O’Rourke.

Benton added, “Merging makes a great deal of sense. Our combined consulting practice provides a scalable alternative to Tier 1 corporate service companies, which usually pursue larger multi-service opportunities.”

The company will be exhibiting (Booth 122) May 1 to 5 at the Association for Research in Vision and Ophthalmology annual meeting in Fort Lauderdale, FL.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.